Colon CancerABPNCT00817934
Safe, Effective, and More Tolerable 16 Tablets Colon Prep
An observational study of Colon Cancer, run by Long Neck Medical Enterprises at 1 site in United States.
Trial summary
The purpose of this study is determine if the AB Prep (a 16 tablets colon cleansing prep), is an effective, and safe colon cleansing prep in preparation for colonoscopy, and severe constipation. Read more about this study
- Who is it for?
- Ages 12 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Colon Cancer
- What is being tested?
- AB PREP
- Type of treatment
- Pill or oral medicine
- How many people
- 400 participants
- Where
- 1 siteUnited States
- Study dates
- Jan 2009to Jan 2010
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 75 years
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Any patient between the age of 12 and 75, who is eligible for colonoscopy.
Who may be able to join
- Any eligible patient for colonoscopy
Who cannot join
- Patients with renal failure
Trial locations and contacts
1 site in 1 country.
United States1 site
Cedar Tree Surgical Center
Millsboro, Delaware, 19966
About this study
Official title: Phase III of the AB Prep Safety and Efficacy in Colon Cleansing
The purpose of this study is determine if the AB Prep (a 16 tablets colon cleansing prep), is an effective, and safe colon cleansing prep in preparation for colonoscopy, and severe constipation.
Read the detailed description
The available colon cleansing preps have issues with patient's tolerance( Abdominal pain, nausea, vomiting), and as recently noted by the FDA safety issues such a change in EKG, blood electrolytes requiring 72 hours to correct, and most recently PO4 nephropathy.
The AB Prep is a 16 tablets prep that has excellent patient's tolerance efficacy, with no change in blood electrolytes or EKG. ( PhaseI (20 patients) and Phase II (200 patients)
The protocol that was used is as follows:
(IND application # 75,704)
Protocol design for testing the safety and efficacy of the AB Prep:
The AB Prep is a combination of 2 Reglan tablets (10mg each), 6 Dulcolax tablets, and 8 K-Phos Neutral tablets. The combination is given in two steps, four hours apart; the day before the colonoscopy.
As before, the objective of this clinical trial is to examine the AB Prep first and foremost for safety, and second for efficacy of colon cleansing.
The proposed trial is for One-Arm Study of subjects undergoing elective and therapeutic colonoscopy.
Phase III: 400 patients, The selection will be random, the age probably ranging from 12 to 75 years old.
The patients will have a Pre, and post procedural EKG, comprehensive (Sodium, Potassium, Creatinine, BUN, Calcium, Magnesium, Phosphate, Glucose), and vital signs.
The patients with severe constipation (One bowel movement per week or more) will not be included in the study. (In our experience, those people required two days prep to achieve colon cleansing).
The SRSS statistical program will be used for data collection and analysis:
The end point of the study is colon cleansing, adequate enough to perform colonoscopy. The colon cleansing will be graded as follow:
- Poor colon prep, unable to proceed with colonoscopy.
- Able to do colonoscopy with, the colon cleansing labeled as:
A- Excellent, Totally cleansed B- Good, adequately cleansed, with need for irrigation.
In addition to efficacy, we would like to check for patient's satisfaction and compliance, (Most common complaints that the patients tend to voice with the present approved colon preps).
Patient's satisfaction data will be collected before the procedure and will be graded as follow:
- Totally satisfied with the Prep, without any complaints
- Satisfied, with the following complaints (Nausea, vomiting, abdominal pain/cramping)
- Unsatisfied with the Prep (Reasons!!!)
Patient's compliance will be graded as follow:
- Compliant
- Non compliant(Reasons).
The prep instruction will be as follows REPARATION FOR COLONOSCOPY
FIVE DAYS before your procedure:
- If you take COUMADIN or PLAVIX, we recommend that you stop these medications. You must contact your primary care physician or cardiologist for specific instructions. You may restart these medications again after the procedure unless otherwise instructed.
- If you have DIABETES and take medication to control your blood sugar, contact your primary care physician or diabetes doctor for instructions about how to take your diabetes medication while preparing for this procedure.
- Stop taking iron or multivitamins that contain iron.
- Avoid the use of aspirin and aspirin-like medications such as ibuprofen, Advil and Aleve. These medicines may increase your risk of bleeding after polyp removal.
- Start a low-roughage diet and do not eat corn or raw vegetables. You may re-start your usual diet after the procedure.
TWO DAYS before the procedure:
- Take 2 tablets of Dulcolax at 8:00 PM.
ONE DAY before the procedure:
- Begin a clear liquid diet at breakfast and continue this diet until 4 hours before your procedure. A clear liquid diet includes: water, tea, black coffee, clear broth, apple juice, white grape juice, Gatorade, soda, Jell-O. Do not eat or drink anything red, including red Jell-O. Do not drink milk. Do not use sugar-free drinks. All patients, including those with DIABETES, should be sure they get enough sugar during this time.
- At 8:00 AM, take One Reglan(10mg) tablet, 2 Dulcolax tablets, and 4 tablets of K-PHOS NEUTRAL. Drink three glasses of water/juice SLOWLY over 1 hour. The laxative effect begins in about 2 hours. BE SURE TO DRINK AT LEAST 3 GLASSES OF WATER OR JUICE AFTER TAKING EACH DOSE OF THE prep.( Each Glass =350cc)
- At 12:00 Noon, Take 2 Dulcolax tablets and 4 tablets of K-PHOS NEUTRAL, along with 3 glasses of water/Juice.(Each glass =350cc).
ON THE DAY of your procedure:
- Take all of your usual medicines and 1 tablet of Reglan (10mg). Do Not Take Coumadin, Plavix, or Aspirin. If you take INSULIN, take 1/2 your usual dose.
- If you have a medical condition requiring antibiotics before or after procedures, we will determine whether they are needed for your colonoscopy.
- STOP CLEAR LIQUIDS 4 HOURS BEFORE YOUR PROCEDURE (except for small amount of water with medications). DO NOT EAT OR DRINK ANYTHING UNTIL AFTER YOUR PROCEDURE.
- Wear loose-fitting, comfortable clothes.
- Read the consent form. You will be asked to sign the form before your procedure.
Please bring these things WITH YOU to your procedure:
- A list of all of your medications, including the doses
- Your identification or insurance card
- The name and phone number of your escort.
AFTER your procedure:
- You will be monitored in the Endoscopy Unit recovery area for 20-30 minutes.
- You may have some abdominal bloating after the procedure. It should resolve within an hour.
- You may eat your normal diet after the procedure.
- You may return to work the day after the procedure.
HELPFUL HINTS FOR PATIENTS UNDERGOING COLONOSCOPY
1.Use moist wipes (baby wipes) instead of toilet paper.
- Conditions
- Colon Cancer
- Being tested
- AB PREP
- Keywords
- Efficacy, patient's tolerance, patient's safety
- Medical subject headings
- Colonic Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AB PREPDrug
Also called Reglan, K-Phos neutral, and Dulcolax
Potassium phosphate and Sodium Phosphate,(in the form of K-phos neutral 8 tablets.(Bisacodyl)6tablets. The third medication is (Metoclopramide).
| Study group | Role | What they receive |
|---|---|---|
| PREVENTION AND TREATMENT | PATIENTS 50 YEARS AND OLDER REQUIRE SCREENING COLONOSCOPY. PATIENTS WITH FAMILY HISTORY OF COLON CANCER WILL REQUIRE IT BEFORE THE AGE OF 50. Receives: Drug: AB PREP |
What is being measured
The primary outcome is the main question the study is designed to answer.
TOTAL COLON CLEANSING, TO BE ABLE TO PERFORM COLONOSCOPY
Measured: IMMEDIATE, DURING THE COLONOSCOPY
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Jan 2009 (estimated)
- Study startJan 2009
- Primary completionJan 2010 (estimated)
- Study completionJan 2010 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Colon CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 400 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Long Neck Medical Enterprises
- Sponsor type
- University, hospital or other
- Collaborators
- National Institutes of Health (NIH)
- Investigators
- SEMAAN M ABBOUD, MD, Principal investigator
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00817934
- Sponsor's protocol ID
- ABBPREP1
- Other IDs
- AB1
- Acronym
- ABP
- Status last verified
- Jan 2009
- First submitted
- 5 Jan 2009
- Last updated
- 7 Jan 2009
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 7 Jan 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Phase III of the AB Prep Safety and Efficacy in Colon Cleansing
- ClinicalTrials.gov ID
- NCT00817934
- Acronym / sponsor ID
- ABP / ABBPREP1
- Conditions
- Colon Cancer
- Keywords
- Efficacy, patient's tolerance, patient's safety
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 400 participants (estimated)
- Lead sponsor
- Long Neck Medical EnterprisesUniversity, hospital or other
- Collaborators
- National Institutes of Health (NIH)
- Study start
- Jan 2009
- Primary completion
- Jan 2010 (estimated)
- Study completion
- Jan 2010 (estimated)
- First posted
- 7 Jan 2009 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is determine if the AB Prep (a 16 tablets colon cleansing prep), is an effective, and safe colon cleansing prep in preparation for colonoscopy, and severe constipation.
Detailed description
The available colon cleansing preps have issues with patient's tolerance( Abdominal pain, nausea, vomiting), and as recently noted by the FDA safety issues such a change in EKG, blood electrolytes requiring 72 hours to correct, and most recently PO4 nephropathy.
The AB Prep is a 16 tablets prep that has excellent patient's tolerance efficacy, with no change in blood electrolytes or EKG. ( PhaseI (20 patients) and Phase II (200 patients)
The protocol that was used is as follows:
(IND application # 75,704)
Protocol design for testing the safety and efficacy of the AB Prep:
The AB Prep is a combination of 2 Reglan tablets (10mg each), 6 Dulcolax tablets, and 8 K-Phos Neutral tablets. The combination is given in two steps, four hours apart; the day before the colonoscopy.
As before, the objective of this clinical trial is to examine the AB Prep first and foremost for safety, and second for efficacy of colon cleansing.
The proposed trial is for One-Arm Study of subjects undergoing elective and therapeutic colonoscopy.
Phase III: 400 patients, The selection will be random, the age probably ranging from 12 to 75 years old.
The patients will have a Pre, and post procedural EKG, comprehensive (Sodium, Potassium, Creatinine, BUN, Calcium, Magnesium, Phosphate, Glucose), and vital signs.
The patients with severe constipation (One bowel movement per week or more) will not be included in the study. (In our experience, those people required two days prep to achieve colon cleansing).
The SRSS statistical program will be used for data collection and analysis:
The end point of the study is colon cleansing, adequate enough to perform colonoscopy. The colon cleansing will be graded as follow:
- Poor colon prep, unable to proceed with colonoscopy.
- Able to do colonoscopy with, the colon cleansing labeled as:
A- Excellent, Totally cleansed B- Good, adequately cleansed, with need for irrigation.
In addition to efficacy, we would like to check for patient's satisfaction and compliance, (Most common complaints that the patients tend to voice with the present approved colon preps).
Patient's satisfaction data will be collected before the procedure and will be graded as follow:
- Totally satisfied with the Prep, without any complaints
- Satisfied, with the following complaints (Nausea, vomiting, abdominal pain/cramping)
- Unsatisfied with the Prep (Reasons!!!)
Patient's compliance will be graded as follow:
- Compliant
- Non compliant(Reasons).
The prep instruction will be as follows REPARATION FOR COLONOSCOPY
FIVE DAYS before your procedure:
- If you take COUMADIN or PLAVIX, we recommend that you stop these medications. You must contact your primary care physician or cardiologist for specific instructions. You may restart these medications again after the procedure unless otherwise instructed.
- If you have DIABETES and take medication to control your blood sugar, contact your primary care physician or diabetes doctor for instructions about how to take your diabetes medication while preparing for this procedure.
- Stop taking iron or multivitamins that contain iron.
- Avoid the use of aspirin and aspirin-like medications such as ibuprofen, Advil and Aleve. These medicines may increase your risk of bleeding after polyp removal.
- Start a low-roughage diet and do not eat corn or raw vegetables. You may re-start your usual diet after the procedure.
TWO DAYS before the procedure:
- Take 2 tablets of Dulcolax at 8:00 PM.
ONE DAY before the procedure:
- Begin a clear liquid diet at breakfast and continue this diet until 4 hours before your procedure. A clear liquid diet includes: water, tea, black coffee, clear broth, apple juice, white grape juice, Gatorade, soda, Jell-O. Do not eat or drink anything red, including red Jell-O. Do not drink milk. Do not use sugar-free drinks. All patients, including those with DIABETES, should be sure they get enough sugar during this time.
- At 8:00 AM, take One Reglan(10mg) tablet, 2 Dulcolax tablets, and 4 tablets of K-PHOS NEUTRAL. Drink three glasses of water/juice SLOWLY over 1 hour. The laxative effect begins in about 2 hours. BE SURE TO DRINK AT LEAST 3 GLASSES OF WATER OR JUICE AFTER TAKING EACH DOSE OF THE prep.( Each Glass =350cc)
- At 12:00 Noon, Take 2 Dulcolax tablets and 4 tablets of K-PHOS NEUTRAL, along with 3 glasses of water/Juice.(Each glass =350cc).
ON THE DAY of your procedure:
- Take all of your usual medicines and 1 tablet of Reglan (10mg). Do Not Take Coumadin, Plavix, or Aspirin. If you take INSULIN, take 1/2 your usual dose.
- If you have a medical condition requiring antibiotics before or after procedures, we will determine whether they are needed for your colonoscopy.
- STOP CLEAR LIQUIDS 4 HOURS BEFORE YOUR PROCEDURE (except for small amount of water with medications). DO NOT EAT OR DRINK ANYTHING UNTIL AFTER YOUR PROCEDURE.
- Wear loose-fitting, comfortable clothes.
- Read the consent form. You will be asked to sign the form before your procedure.
Please bring these things WITH YOU to your procedure:
- A list of all of your medications, including the doses
- Your identification or insurance card
- The name and phone number of your escort.
AFTER your procedure:
- You will be monitored in the Endoscopy Unit recovery area for 20-30 minutes.
- You may have some abdominal bloating after the procedure. It should resolve within an hour.
- You may eat your normal diet after the procedure.
- You may return to work the day after the procedure.
HELPFUL HINTS FOR PATIENTS UNDERGOING COLONOSCOPY
1.Use moist wipes (baby wipes) instead of toilet paper.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| PREVENTION AND TREATMENT | – | Drug: AB PREPPATIENTS 50 YEARS AND OLDER REQUIRE SCREENING COLONOSCOPY. PATIENTS WITH FAMILY HISTORY OF COLON CANCER WILL REQUIRE IT BEFORE THE AGE OF 50. |
Who may qualify
- Ages
- 12 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Any patient between the age of 12 and 75, who is eligible for colonoscopy.
Key inclusion criteria (1 listed)
- Any eligible patient for colonoscopy
Key exclusion criteria (1 listed)
- Patients with renal failure
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AB PREPAlso: Reglan, K-Phos neutral, and DulcolaxPotassium phosphate and Sodium Phosphate,(in the form of K-phos neutral 8 tablets.(Bisacodyl)6tablets. The third medication is (Metoclopramide). | Drug | PREVENTION AND TREATMENT |
Primary outcome
TOTAL COLON CLEANSING, TO BE ABLE TO PERFORM COLONOSCOPY
Time frame: IMMEDIATE, DURING THE COLONOSCOPY
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jan 2009.
Related trials for Colon Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Toripalimab Plus Cetuximab and Irinotecan for Second-Line Right-Sided RAS/BRAF Wild-Type Advanced Colon Cancer Phase II Study
Colorectal Cancer (CRC)
Not yet recruiting
FLuorescent Angiography in REduction of Anastomotic Leak in Rectal Cancer Surgery
Rectal Cancer Patients, Rectal Cancer Surgery
Not yet recruiting
A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.
NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Cancer)
Not yet recruitingPhase 1
A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors
Advanced Breast Cancer, Advanced or Metastatic Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
SEMAAN M ABBOUD, MD principal investigator
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Colon Cancer, run by Long Neck Medical Enterprises at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 7 Jan 2009. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
TOTAL COLON CLEANSING, TO BE ABLE TO PERFORM COLONOSCOPY (time frame: IMMEDIATE, DURING THE COLONOSCOPY). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2009.